Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition.

Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T, Jaeger W.

Cancer Lett. 2008 Mar 18;261(2):172-82. Epub 2007 Dec 20.

PMID:
18082939
2.

Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling.

Spatzenegger M, Liu H, Wang Q, Debarber A, Koop DR, Halpert JR.

J Pharmacol Exp Ther. 2003 Jan;304(1):477-87.

PMID:
12490624
3.
4.

Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles.

Spatzenegger M, Wang Q, He YQ, Wester MR, Johnson EF, Halpert JR.

Mol Pharmacol. 2001 Mar;59(3):475-84.

PMID:
11179442
5.

CYP1A1 but not CYP1A2 proteins are expressed in human lymphocytes.

Spatzenegger M, Horsmans Y, Verbeeck RK.

Pharmacol Toxicol. 2000 May;86(5):242-4. No abstract available.

PMID:
10862507
6.
7.

Metabolism of dextromethorphan in human liver microsomes: a rapid HPCL assay to monitor cytochrome P450 2D6 activity.

Vielnascher E, Spatzenegger M, Mayrhofer A, Klinger P, Jäger W.

Pharmazie. 1996 Aug;51(8):586-8.

PMID:
8794469
8.
9.

Clinical importance of hepatic cytochrome P450 in drug metabolism.

Spatzenegger M, Jaeger W.

Drug Metab Rev. 1995;27(3):397-417. Review. No abstract available.

PMID:
8521748

Supplemental Content

Loading ...
Support Center